EL
WST icon

EWA LLC’s West Pharmaceutical WST Stock Holding History

EWA LLC’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-648
Closed -$205K – 179
2024
Q2 		$205K Sell
648
-55
-8% -$19.4K 0.08% 129
2024
Q1 		$256K Sell
703
-52
-7% -$19.2K 0.12% 87
2023
Q4 		$288K Sell
755
-72
-9% -$25.5K 0.14% 66
2023
Q3 		$280K Buy
827
+113
+16% +$43.7K 0.18% 58
2023
Q2 		$273K Buy
714
+2
+0.3% +$714 0.19% 48
2023
Q1 		$256K Buy
+712
New +$208K 0.19% 46

Other funds holding WST

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
APG Asset Management
APG Asset Management Amsterdam, Netherlands $40.7B AUM 39.97% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

EWA LLC's WST Position: Q3 2024 in Review

EWA LLC sold out of West Pharmaceutical (WST) in Q3 2024, closing a stake of 648 shares — an estimated $205K sold.

EWA LLC first reported a position in WST in Q1 2023 and held it in 6 quarters. The position peaked at $288K in Q4 2023. 730 funds tracked by Wall St. Rank hold WST as of Q3 2024.

  • EWA LLC reported no remaining West Pharmaceutical position as of Q3 2024 after selling out during the quarter.
  • EWA LLC sold 648 West Pharmaceutical shares in Q3 2024, an estimated $205K.
  • EWA LLC first reported a position in West Pharmaceutical in Q1 2023 and held it in 6 quarters.
  • EWA LLC's West Pharmaceutical position peaked at $288K in Q4 2023.
  • 730 funds tracked by Wall St. Rank held West Pharmaceutical as of Q3 2024.

Based on EWA LLC's 13F filing for Q3 2024, filed 15 Nov 2024.